Microbot Medical Inc.
MBOT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000883975
No open-market purchases or sales by Microbot Medical Inc. insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $22.1M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Microbot Medical Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −4 vs. Q2 2021
- Shares held
- 778.1K
- +23.2K (+3.1%) vs. Q2 2021
- Total value
- $5.47M
- −$526.0K (−8.8%) vs. Q2 2021
- New holders
- 0
- 6 more added
- Sold out
- 4
- 4 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 71 | $22.1M |
| Q1 2026 | 79 | $34.3M |
| Q4 2025 | 71 | $22.8M |
| Q3 2025 | 68 | $27.4M |
| Q2 2025 | 50 | $11.1M |
| Q1 2025 | 44 | $3.26M |
| Q4 2024 | 39 | $1.24M |
| Q3 2024 | 26 | $933.4K |
| Q2 2024 | 36 | $1.11M |
| Q1 2024 | 33 | $1.77M |
| Q4 2023 | 36 | $2.49M |
| Q3 2023 | 31 | $1.40M |
| Q2 2023 | 28 | $3.36M |
| Q1 2023 | 29 | $2.94M |
| Q4 2022 | 24 | $4.48M |
| Q3 2022 | 23 | $3.84M |
| Q2 2022 | 25 | $3.60M |
| Q1 2022 | 27 | $4.65M |
| Q4 2021 | 27 | $6.10M |
| Q3 2021 | 25 | $5.47M |
| Q2 2021 | 29 | $6.00M |
| Q1 2021 | 25 | $6.77M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Microbot Medical Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 270,695 | $1.90M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 155,013 | $1.09M | 0.00% | +16,205+11.7% | Added |
| AlphaCentric Advisors LLC | 100,000 | $703.0K | 0.18% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 95,064 | $668.0K | 0.00% | +41,686+78.1% | Added |
| Geode Capital Management, LLC | 50,504 | $355.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 34,770 | $244.0K | 0.00% | +300+0.9% | Added |
| Morgan Stanley | 19,438 | $137.0K | 0.00% | +15,934+454.7% | Added |
| Bank of New York Mellon Corp | 15,610 | $110.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 11,878 | $84.0K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 11,600 | $82.0K | 0.00% | 00.0% | Unchanged |
| Investment Management Associates Inc | 10,000 | $70.0K | 0.04% | 00.0% | Unchanged |
| Bank of America Corp | 1,377 | $9.00K | 0.00% | +1,310+1,955.2% | Added |
| Wells Fargo & Company | 1,242 | $8.00K | 0.00% | −2−0.2% | Reduced |
| Royal Bank of Canada | 611 | $4.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 205 | $1.00K | 0.00% | −10−4.7% | Reduced |
| Patriot Financial Group Insurance Agency, LLC | 80 | $1.00K | 0.00% | 00.0% | Unchanged |
| Brewin Dolphin Ltd | 1 | $7 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2 | $0 | 0.00% | −535−99.6% | Reduced |
| Barclays PLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 6 | $0 | 0.00% | +5+500.0% | Added |
| Harbour Investments, Inc. | 1 | $0 | 0.00% | −1−50.0% | Reduced |
| Bourgeon Capital Management LLC | 13 | $0 | 0.00% | 00.0% | Unchanged |
| Jacobi Capital Management LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Pacific Center for Financial Services | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Alaethes Wealth LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −40,113−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,194−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −418−100.0% | Sold out |